Carao Ventures — 2019 Investments

1 investments dated 2019 · listed companies and verified rows first · show all

Speratumsperatum.com in 𝕏Jan 2019

Speratum Biopharma develops RNA interference (RNAi) therapeutics for cancer and other hard-to-treat genetic diseases, using its proprietary NoPass RNAi design platform and Nano-In nanoparticle delivery system.

BiotechDeep TechHealthtech

Christian Marín Müller(Founder)in

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.